JP3463000004
JP3463000004
TAKEDA PHARMACEUTICAL CO LTD
Loading chart...
Solid Quality Asset with Moderate Fluctuation
Healthy balance: Exemplary business financials (Health Score: 60/100) paired with moderate price swings for a single equity (±19.3% p.a.). The score (5/7) reflects the standard baseline for equities under SRI rules.
Volatility Risk
Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.
Volatility Risk Score
5/7 Elevated
5 / 7 SRI Price Fluctuation & Beta
Above-average volatility. Suitable for experienced investors with high risk tolerance (5+ years horizon). Moves noticeably less than the broader market (0.1x).
Beta (Market Relation)
0.1x
DefensiveVolatility (5Y p.a.)
19.3% p.a.
5-Year HorizonMax Drawdown (5Y)
-19.7%
5-Year HorizonSharpe Ratio
0.52
Return / RiskElevated Risk / Growth: Score Basis:
Multi-Horizon Risk & Performance Matrix
Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.
Timeframe | Volatility (p.a.) | Max Drawdown | Sharpe Ratio | Return (p.a.) |
|---|---|---|---|---|
| 1 Year | — | — | — | +34.8% |
| 3 Years | 20.7% | -19.4% | 0.29 | +8.5% |
| 5 Years | 19.3% | -19.7% | 0.52 | +12.8% |
| 10 Years | 22.8% | -56.5% | -0.03 | +1.8% |
Automated Risk & Health Notes (Red Flags)
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Unprofitable business model: The company is currently generating net losses.
Historical Stress Test: Maximum peak-to-trough drawdown of -56.5% in the extended horizon.
Corporate Governance & ISS Scores
Overall Governance Risk
1 ISS Score: 1 / 10
Audit Risk
1 ISS Score: 1 / 10
Board Risk
1 ISS Score: 1 / 10
Short Ratio
-